Cargando…
Monitoring clinical progression with mitochondrial disease biomarkers
Mitochondrial disorders are genetically determined metabolic diseases due to a biochemical deficiency of the respiratory chain. Given that multi-system involvement and disease progression are common features of mitochondrial disorders they carry substantial morbidity and mortality. Despite this, no...
Autores principales: | Steele, Hannah E, Horvath, Rita, Lyon, Jon J, Chinnery, Patrick F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841218/ https://www.ncbi.nlm.nih.gov/pubmed/28969370 http://dx.doi.org/10.1093/brain/awx168 |
Ejemplares similares
-
Detecting new neurodegenerative disease genes: does phenotype accuracy limit the horizon?
por: Samuels, David C., et al.
Publicado: (2009) -
Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases
por: Betts, Matthew J, et al.
Publicado: (2019) -
Update of: Choi and Short Fabic, Monitoring Progress in Equality for the Sustainable Development Goals: A Case Study of Meeting Demand for Family Planning
Publicado: (2018) -
The potential of serum neurofilament as biomarker for multiple sclerosis
por: Bittner, Stefan, et al.
Publicado: (2021) -
The era of continuous glucose monitoring and its expanded role in type 2 diabetes
por: Yu, Jin, et al.
Publicado: (2023)